HRSA-25-063: Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 47 awards worth $175 million in total. Applications closed on October 22, 2024.
From the official notice on Grants.gov, last changed August 22, 2024. Checked November 7, 2026.
- Total funding$175 million
- Expected awards47
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | August 22, 2024 |
|---|---|
| Deadline | October 22, 2024 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
RWHAP Part A funded Eligible Metropolitan Area (EMA) or Transitional Grant Area (TGA) whose service area includes one or more of the identified 48 HIV high burden counties; and the EMAs of Washington, D.C. and San Juan, PR. RWHAP Part B funded States/Territories identified as having a substantial rural HIV burdenAlabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina. The RWHAP Part B Program of the State of Ohio on behalf of Hamilton County. These types of domestic organizations may apply Domestic means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice (HRSA-25-063)-announces the opportunity to apply for funding for the Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B cooperative agreement. The purpose of this initiative is to focus resources in 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states with the highest incidence or burden of HIV to implement effective and innovative strategies, interventions, approaches, and services to reduce new HIV infections in the United States. The Ending the HIV Epidemic in the U.S. (hereafter referred to as the “EHE initiative”) focuses on four key strategies: •Diagnose all people with HIV as early as possible; •Treat people with HIV rapidly and effectively to reach sustained viral suppression; •Prevent new HIV transmissions by using proven interventions; and •Respond quickly to potential HIV outbreaks to get needed prevention and treatment services to people who need them. HRSA and the Centers for Disease Control and Prevention (CDC), along with the National Institutes of Health (NIH) Centers for AIDS Research (CFARs), the Indian Health Service (IHS), Department of Housing and Urban Development (HUD), and the Substance Abuse and Mental Health Services Administration (SAMHSA) are collaborating on implementation of these key strategies. HRSA’s responsibilities include increasing testing and prevention among Health Center Program patients, providing access to HIV care and treatment through the RWHAP and Health Center Program, and linking people with HIV, newly diagnosed or re-identified through testing programs, to care, and responding to outbreaks. For the Ryan White Program, the EHE initiative expands the program’s ability to meet the needs of clients, specifically focusing on linking people with HIV who are either newly diagnosed, diagnosed but currently not in care, or are diagnosed and in care but not yet virally suppressed, to the essential HIV care, treatment, and support services needed to help them reach viral suppression.
Who has won Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B grants before
From fiscal 2021 to 2025, Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B (93.686) awarded $214 million across 49 grant awards, an average of $4.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| City of New York | New York | 1 | $26.5 million |
| County of Los Angeles | California | 1 | $12.3 million |
| County of Fulton | Georgia | 1 | $7.9 million |
| Chicago Department of Public Health | Illinois | 1 | $7.2 million |
| Harris County | Texas | 1 | $7.1 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-25-063 still open?
No. It closed on October 22, 2024.
Who can apply for Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B?
Closed October 22, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $175 million in total across about 47 awards.
Who has won Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B grants before?
The largest recipients over five fiscal years were City of New York, County of Los Angeles, County of Fulton. The program made 49 awards worth $214 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)